Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: SGLT2i Apr 15 | 2019CREDENCE Demonstrates 30% RRR in Renal Outcomes; Nephros Likely New Priority Prescribers For InvokanaPurchase Blast
$599
Posted in: GLP-1RA Apr 10 | 2019New US Ozempic 3mL Pen Offering for Maintenance DosingPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Apr 10 | 2019New Sanofi Insulin Savings ProgramPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Apr 09 | 2019PBMs Take Center Stage at Third Senate Drug Pricing HearingPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Apr 09 | 2019New Medtronic/BCBS CGM Outcomes-Based ContractPurchase Blast
$599
Posted in: Glucose Monitoring Apr 05 | 2019CGM: WaveForm and A. Menarini Form Partnership for Ex-US DistributionPurchase Blast
$599
Posted in: Glucose Monitoring Apr 04 | 2019Livongo for Diabetes Integration with Amazon AlexaPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Apr 04 | 2019Sanofi To Layoff Diabetes Sales Reps; Details Remain ScarcePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin Apr 03 | 2019New Cigna/ESI Insulin Savings Program Introduced Ahead of Congressional HearingPurchase Blast
$599
Posted in: Bolus Insulin Mar 28 | 2019Thoughts on Lilly Drug Pricing TransparencyPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Mar 27 | 2019Glytec Partners with Dario For Outpatient Insulin TitrationPurchase Blast
$599
Posted in: SGLT2i Mar 25 | 2019Forxiga T1DM Approved in Europe; Sota EU T1DM Approval ImminentPurchase Blast